These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19619133)

  • 21. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C; Martínez-Cáceres EM
    Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury.
    Penkowa M; Tio L; Giralt M; Quintana A; Molinero A; Atrian S; Vasák M; Hidalgo J
    J Neurosci Res; 2006 May; 83(6):974-84. PubMed ID: 16493670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury.
    Abrams MB; Dominguez C; Pernold K; Reger R; Wiesenfeld-Hallin Z; Olson L; Prockop D
    Restor Neurol Neurosci; 2009; 27(4):307-21. PubMed ID: 19738324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplanted myogenic progenitor cells express neuronal markers in the CNS and ameliorate disease in experimental autoimmune encephalomyelitis.
    Aharoni R; Aizman E; Fuchs O; Arnon R; Yaffe D; Sarig R
    J Neuroimmunol; 2009 Oct; 215(1-2):73-83. PubMed ID: 19766326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells.
    Heo JY; Jing K; Song KS; Seo KS; Park JH; Kim JS; Jung YJ; Hur GM; Jo DY; Kweon GR; Yoon WH; Lim K; Hwang BD; Jeon BH; Park JI
    Stem Cells; 2009 Jun; 27(6):1455-62. PubMed ID: 19492297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells.
    Sargent A; Bai L; Shano G; Karl M; Garrison E; Ranasinghe L; Planchon SM; Cohen J; Miller RH
    Exp Neurol; 2017 Sep; 295():222-232. PubMed ID: 28602834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells and inflammatory lung diseases.
    Iyer SS; Co C; Rojas M
    Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant therapy in multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Immunopharmacol Immunotoxicol; 2009; 31(1):13-29. PubMed ID: 18763202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS.
    Fisher-Shoval Y; Barhum Y; Sadan O; Yust-Katz S; Ben-Zur T; Lev N; Benkler C; Hod M; Melamed E; Offen D
    J Mol Neurosci; 2012 Sep; 48(1):176-84. PubMed ID: 22638856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton.
    Kasper G; Mao L; Geissler S; Draycheva A; Trippens J; Kühnisch J; Tschirschmann M; Kaspar K; Perka C; Duda GN; Klose J
    Stem Cells; 2009 Jun; 27(6):1288-97. PubMed ID: 19492299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis.
    Espejo C; Penkowa M; Demestre M; Montalban X; Martínez-Cáceres EM
    Neuroscience; 2005; 132(4):1135-49. PubMed ID: 16078373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mouse model of experimental antoimmune encephalomyelitisin C57BL/6J and expression of macrophage migration inhibitory factor].
    Gao YC; Wang YZ; Wang R; Yan JJ; Zhou WB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):931-6. PubMed ID: 19001736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma.
    Chen WH; Liu HY; Lo WC; Wu SC; Chi CH; Chang HY; Hsiao SH; Wu CH; Chiu WT; Chen BJ; Deng WP
    Biomaterials; 2009 Oct; 30(29):5523-33. PubMed ID: 19646749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
    Knap B; Prezelj M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2009 Aug; 13(4):300-5. PubMed ID: 19695063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells.
    Schmidt AJ; Hemmeter UM; Krieg JC; Vedder H; Heiser P
    J Psychiatr Res; 2009 May; 43(8):818-23. PubMed ID: 19101687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy.
    Furlani D; Ugurlucan M; Ong L; Bieback K; Pittermann E; Westien I; Wang W; Yerebakan C; Li W; Gaebel R; Li RK; Vollmar B; Steinhoff G; Ma N
    Microvasc Res; 2009 May; 77(3):370-6. PubMed ID: 19249320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metallothionein-I+II in neuroprotection.
    Pedersen MØ; Jensen R; Pedersen DS; Skjolding AD; Hempel C; Maretty L; Penkowa M
    Biofactors; 2009; 35(4):315-25. PubMed ID: 19655389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro nicotine-induced oxidative stress in mice peritoneal macrophages: a dose-dependent approach.
    Mahapatra SK; Das S; Bhattacharjee S; Gautam N; Majumdar S; Roy S
    Toxicol Mech Methods; 2009 Feb; 19(2):100-8. PubMed ID: 19778253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential time-course of the increase of antioxidant thiol-defenses in the acute phase after spinal cord injury in rats.
    Diaz-Ruiz A; Alcaraz-Zubeldia M; Maldonado V; Salgado-Ceballos H; Mendez-Armenta M; Rios C
    Neurosci Lett; 2009 Mar; 452(1):56-9. PubMed ID: 19159657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.